- Home
- OGEN vs WLGS Comparison
OGEN vs WLGS Comparison
Compare OGEN & WLGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- WLGS
- Stock Information
- Founded
- OGEN 1996
- WLGS 1981
- Country
- OGEN United States
- WLGS Hong Kong
- Employees
- OGEN N/A
- WLGS N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- WLGS Engineering & Construction
- Sector
- OGEN Health Care
- WLGS Consumer Discretionary
- Exchange
- OGEN Nasdaq
- WLGS Nasdaq
- Market Cap
- OGEN 4.6M
- WLGS 4.4M
- IPO Year
- OGEN N/A
- WLGS 2023
- Fundamental
- Price
- OGEN $4.13
- WLGS $0.05
- Analyst Decision
- OGEN
- WLGS
- Analyst Count
- OGEN 0
- WLGS 0
- Target Price
- OGEN N/A
- WLGS N/A
- AVG Volume (30 Days)
- OGEN 656.3K
- WLGS 37.9M
- Earning Date
- OGEN 08-08-2025
- WLGS 08-14-2025
- Dividend Yield
- OGEN N/A
- WLGS N/A
- EPS Growth
- OGEN N/A
- WLGS N/A
- EPS
- OGEN N/A
- WLGS N/A
- Revenue
- OGEN N/A
- WLGS $3,951,649.00
- Revenue This Year
- OGEN N/A
- WLGS N/A
- Revenue Next Year
- OGEN N/A
- WLGS N/A
- P/E Ratio
- OGEN N/A
- WLGS N/A
- Revenue Growth
- OGEN N/A
- WLGS N/A
- 52 Week Low
- OGEN $3.12
- WLGS $0.04
- 52 Week High
- OGEN $75.60
- WLGS $9.66
- Technical
- Relative Strength Index (RSI)
- OGEN 47.04
- WLGS 25.41
- Support Level
- OGEN $3.41
- WLGS $0.05
- Resistance Level
- OGEN $4.85
- WLGS $0.05
- Average True Range (ATR)
- OGEN 0.58
- WLGS 0.02
- MACD
- OGEN 0.01
- WLGS 0.01
- Stochastic Oscillator
- OGEN 42.49
- WLGS 3.27
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About WLGS Wang & Lee Group Inc.
WANG & LEE Group Inc operates as an investment holding company. The firm conducts its primary operations through its indirectly wholly owned subsidiary WANG and LEE CONTRACTING LIMITED. WLHK provides contract engineering, installation, and out-fitting of the following products and services: low voltage electrical systems, mechanical ventilation and air-conditioning systems (MVAC), fire safety systems, water supply and sewage disposal systems, and site project management.